Medication info
Astroten 10 mg (Rosuvastatin Calcium)

Astroten 10 mg (Rosuvastatin Calcium)

Prescription medicationTabletOral
Ingredient · strength
Rosuvastatin Calcium›10.4mg / 1 tablet
Manufacturer / importer
SK Chemicals Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201001029 · Approved 2010.01.29 · Insurance code 644703330

Summary

Main use
Improves dyslipidemia, slows the progression of atherosclerosis, and prevents cardiovascular disease
Who takes it
Adults · Children
Adult dose
Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia: Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The starting dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which is sufficient for most patients. The maintenance dose should be appropriately adjusted at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response, and may be increased up to a maximum of 20 mg daily. Elderly patients: No dosage adjustment is necessary. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this medicine to patients with moderate renal impairment. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended starting dose is 5 mg. Administration of the 40 mg dose is contraindicated. Patients predisposed to myopathy: The recommended starting dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of this medicine is contraindicated in some of these patients.
Child dose
Pediatric patients with heterozygous familial hypercholesterolemia (ages 10 to 17 years): The usual dosage range is 5 mg to 20 mg once daily. (There are no clinical data on administering doses greater than 20 mg to pediatric patients.) Children under 10 years of age: Safety and efficacy have not been established.

Ingredients

Manufacturer
SK Chemicals Co., Ltd.

Efficacy & effects

Improves dyslipidemia, slows the progression of atherosclerosis, and prevents cardiovascular disease

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • hypercholesterolemia
  • homozygous familial hypercholesterolemia
  • dysbetalipoproteinemia
  • increased high-sensitivity C-reactive protein
  • hypertension
  • low HDL cholesterol levels
  • smoking
  • family history of premature coronary artery disease.
View approved original text

This medication is primarily used as an adjunct in patients with primary hypercholesterolemia, mixed hyperlipidemia, and specific familial hypercholesterolemia who are not adequately controlled by diet and exercise. In pediatric patients, it is also used as an adjunct to diet in cases of elevated LDL cholesterol levels and risk factors for early cardiovascular disease. Additionally, this drug helps lower total cholesterol and LDL cholesterol in patients with hypercholesterolemia, thereby delaying the progression of atherosclerosis. It is also used as an adjunct to diet in patients with primary dysbetalipoproteinemia. Moreover, it contributes to reducing the risk of stroke, myocardial infarction, and vascular revascularization in men aged 50 and older and women aged 60 and older who have certain cardiovascular risk factors. It is an effective medication for improving various dyslipidemias and cardiovascular disease risks.

How to take

Adult dose

Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia: Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The starting dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which is sufficient for most patients. The maintenance dose should be appropriately adjusted at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response, and may be increased up to a maximum of 20 mg daily. Elderly patients: No dosage adjustment is necessary. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this medicine to patients with moderate renal impairment. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended starting dose is 5 mg. Administration of the 40 mg dose is contraindicated. Patients predisposed to myopathy: The recommended starting dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of this medicine is contraindicated in some of these patients.

Child dose

Pediatric patients with heterozygous familial hypercholesterolemia (ages 10 to 17 years): The usual dosage range is 5 mg to 20 mg once daily. (There are no clinical data on administering doses greater than 20 mg to pediatric patients.) Children under 10 years of age: Safety and efficacy have not been established.

Precautions

This medication should not be used in certain patients. For example, it is contraindicated in patients who are allergic to any of the components of this medication, have severe hepatic impairment, or have muscle disorders. It should also be avoided in patients with significantly impaired renal function, pregnant or breastfeeding women, and women of childbearing age who do not use appropriate contraceptive methods. Because this medication can affect liver function and muscles, it is important for patients with a history of hepatic disease or high alcohol consumption to have multiple liver function tests before administration. If symptoms of muscle pain or weakness occur, it is crucial to consult a doctor immediately, and in severe cases, the medication should be discontinued. This medication contains lactose, so it is not suitable for patients with lactose intolerance or specific genetic diseases. Furthermore, due to numerous interactions with other medications, patients should inform their doctor or pharmacist of any other medications they are currently taking. Particularly, the risk of muscle-related side effects may increase when taken with certain antiviral agents, immunosuppressants, antifungals, and antibiotics. Pregnant or breastfeeding women should not use this medication, and women who may become pregnant should use appropriate contraceptive methods during treatment. In case of overdose, there is no specific antidote, so treatment should be based on symptoms, and liver function as well as muscle enzyme levels should be monitored regularly. Serious side effects, such as interstitial lung disease, severe liver damage, myopathy, kidney problems, etc. can occur rarely, so if any abnormal symptoms appear, immediate consultation with healthcare professionals is necessary. Caution is needed when driving or operating machinery as dizziness may occur. Finally, this medication may exhibit higher concentrations in Asian populations, potentially necessitating dosage adjustments.

Side effects

Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, shortness of breath, diarrhea, ophthalmoplegic myasthenia, thrombocytopenia, jaundice, hepatitis, elevated transaminases, Stevens-Johnson syndrome, drug-induced erythema multiforme, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, liver failure, cognitive impairment, elevated ALT, chest pain, muscle cramps, gout, erectile dysfunction, elevated AST, joint pain, fatigue, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air and moisture. It is advisable to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature to preserve the drug's efficacy and safety over time.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.